Company · Toronto, Ontario, Canada
Elvium Life Sciences
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 23
- 19 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 27
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BIPHENTINStatus since Sep 2020 | 02277131 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277158 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277166 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277174 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277182 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277190 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277204 | Marketed | |
| BIPHENTINStatus since Sep 2020 | 02277212 | Marketed | |
| COSOPTStatus since Aug 2020 | 02240113 | Marketed | |
| COSOPT PRESERVATIVE-FREEStatus since May 2022 | 02258692 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470292 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470306 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470314 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470322 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470330 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470349 | Marketed | |
| FOQUESTStatus since Sep 2020 | 02470357 | Marketed | |
| TIMOPTICStatus since Sep 2020 | 00451207 | Marketed | |
| TIMOPTIC-XEStatus since Sep 2020 | 02171899 | Marketed | |
| TRUSOPTStatus since Dec 2025 | 02216205 | Cancelled Post Market | |
| TRUSOPT PRESERVATIVE-FREEStatus since Nov 2024 | 02269090 | Cancelled Post Market | |
| UNIPHYLStatus since Dec 2020 | 02014165 | Cancelled Post Market | |
| UNIPHYLStatus since Dec 2020 | 02014181 | Cancelled Post Market |
Notices of Compliance
Newest first.
- BIPHENTINJuly 15, 2026 · NOC 37931 · Supplement to a New Drug Submission (SNDS)
- FOQUESTJuly 31, 2024 · NOC 33730 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINJune 6, 2024 · NOC 33410 · Supplement to a New Drug Submission (SNDS)
- FOQUESTJune 5, 2024 · NOC 33394 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINJune 4, 2024 · NOC 33381 · Supplement to a New Drug Submission (SNDS)
- FOQUESTJanuary 25, 2024 · NOC 32608 · Supplement to a New Drug Submission (SNDS)
- COSOPT; COSOPT PRESERVATIVE-FREEDecember 5, 2023 · NOC 32287 · Supplement to a New Drug Submission (SNDS)
- TRUSOPT; TRUSOPT PRESERVATIVE-FREEDecember 5, 2023 · NOC 32288 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINSeptember 21, 2023 · NOC 31679 · Supplement to a New Drug Submission (SNDS)
- FOQUESTAugust 29, 2023 · NOC 31515 · Supplement to a New Drug Submission (SNDS)
- FOQUESTJuly 27, 2023 · NOC 31323 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINJuly 19, 2023 · NOC 31241 · Supplement to a New Drug Submission (SNDS)
- TIMOPTIC-XEDecember 9, 2022 · NOC 29665 · Supplement to a New Drug Submission (SNDS)
- TIMOPTICOctober 25, 2022 · NOC 29321 · Supplement to a New Drug Submission (SNDS)
- FOQUESTSeptember 28, 2022 · NOC 29100 · Supplement to a New Drug Submission (SNDS)
- TRUSOPT; TRUSOPT PRESERVATIVE-FREEJuly 12, 2022 · NOC 28576 · Supplement to a New Drug Submission (SNDS)
- COSOPT; COSOPT PRESERVATIVE-FREEMay 24, 2022 · NOC 28248 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINSeptember 2, 2021 · NOC 26612 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINDecember 9, 2020 · NOC 24765 · Supplement to a New Drug Submission (SNDS)
- UNIPHYLOctober 2, 2020 · NOC 24365 · New Drug Submission (NDS)
- ALOXISeptember 9, 2020 · NOC 24199 · New Drug Submission (NDS)
- AKYNZEOSeptember 4, 2020 · NOC 24180 · New Drug Submission (NDS)
- TRUSOPT; TRUSOPT (PRESERVATIVE-FREE)August 26, 2020 · NOC 24126 · New Drug Submission (NDS)
- FOQUESTAugust 25, 2020 · NOC 24102 · New Drug Submission (NDS)
- COSOPT; COSOPT (PRESERVATIVE-FREE)August 20, 2020 · NOC 24082 · New Drug Submission (NDS)
- TIMOPTIC; TIMOPTIC-XEAugust 20, 2020 · NOC 24083 · New Drug Submission (NDS)
- BIPHENTINAugust 14, 2020 · NOC 24049 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Purdue Pharma Foquest Capsule Product Recall (2019-07-25)July 25, 2019 · Drugs · Product safety · Type III
- Foquest Capsule (2018-08-08)August 8, 2018 · Drugs · Product safety · Type III
- Cosopt (dorzolamide hydrochloride/timolol maleate) Preservative-Free Ophthalmic Solution - Risk of Eye Injury - For Health ProfessionalsFebruary 7, 2014 · Drugs · Product safety
- Cosopt (dorzolamide hydrochloride/timolol maleate) Preservative-Free Ophthalmic Solution - Risk of Eye Injury - For the PublicFebruary 7, 2014 · Drugs · Product safety